EUDA Health Holdings Limited (NASDAQ:EUDA) Sees Significant Decline in Short Interest

EUDA Health Holdings Limited (NASDAQ:EUDA) saw a large decline in short interest in September. As of September 15th, there was short interest totaling 1,589 shares, a decline of 38.0% from the August 31st total of 2,561 shares. Approximately 0.1% of the shares of the stock are sold short. Based on an average daily volume of 41,368 shares, the short-interest ratio is currently 0.0 days.

EUDA Health Stock Up 4.8%

EUDA Health stock traded up $0.68 during trading hours on Thursday, hitting $14.98. The stock had a trading volume of 5,889 shares, compared to its average volume of 51,048. EUDA Health has a 1-year low of $5.26 and a 1-year high of $86.00. The stock’s fifty day moving average is $15.56 and its two-hundred day moving average is $13.69.

EUDA Health (NASDAQ:EUDA) last released its quarterly earnings data on Tuesday, September 29th. The company reported ($0.17) EPS for the quarter, missing the consensus estimate of $0.40 by ($0.57). The company had revenue of $1.73 million for the quarter, compared to analyst estimates of $9.61 million.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of EUDA Health in a report on Wednesday, August 5th. One research analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $55.00.

About EUDA Health

EUDA Health Holdings Limited is a digital health company focused on using technology to improve access to healthcare services. The company operates through subsidiaries and develops digital platforms intended to connect patients with healthcare providers and support the delivery of healthcare services.

Its activities include telemedicine and other technology-enabled healthcare solutions, such as facilitating virtual consultations, healthcare appointments and related services. EUDA has also pursued artificial-intelligence applications in sexual health, including technology designed to support the assessment of certain male sexual-health conditions.

The company is based in Singapore and has focused its operations on the Southeast Asian healthcare market.